COGR, representing over 200 U.S. research institutions, submitted comments urging the withdrawal of the proposed Interagency Guidance Framework for Considering the...
Intellectual Property & Innovation
Covering policies and practices for federally sponsored research, Intellectual Property and Innovation ensures discoveries and creative works are effectively protected, managed, and commercialized.
Featured
Technology Transfer in U.S. Research Universities: Dispelling Common Myths (Updated August 2022)
This document, published by COGR, systematically addresses and dispels common misconceptions about technology transfer activities within U.S. research universities...
The Bayh-Dole Act: A Guide to the Law and Implementing Regulations (October 2021 Update)
Originally published in 1999, and updated October 2021:
Resources
Point of Contact
Kevin Wozniak
Director, Research Security & Intellectual Property
All Intellectual Property & Innovation Articles
March-in Rights Under Bayh-Dole
COGR sent comments on march-in rights under the Bayh-Dole Act to the Office of Technology Transfer at the National Institutes of Health.
COGR Testimony at NIH Hearings on March-in Rights
NIH has denied the request from Essential Inventions, Inc. to exercise march-in rights under The Bayh-Dole Act in connection with the pricing of Norvir, marketed by Abbott Laboratories for the treatment of patients with HIV/AIDS. The decision and related materials are available online.
